1. Home
  2. WAVE vs IMRN Comparison

WAVE vs IMRN Comparison

Compare WAVE & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

SELL

Current Price

$3.18

Market Cap

47.5M

Sector

Utilities

ML Signal

SELL

Logo Immuron Limited

IMRN

Immuron Limited

SELL

Current Price

$0.90

Market Cap

7.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WAVE
IMRN
Founded
2011
1994
Country
Israel
Australia
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
7.7M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
WAVE
IMRN
Price
$3.18
$0.90
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $14.75
N/A
AVG Volume (30 Days)
11.0K
★ 13.4K
Earning Date
11-03-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.48
$0.68
52 Week High
$10.87
$1.99

Technical Indicators

Market Signals
Indicator
WAVE
IMRN
Relative Strength Index (RSI) 26.43 34.56
Support Level N/A $0.75
Resistance Level $4.92 $0.89
Average True Range (ATR) 0.40 0.07
MACD -0.06 0.00
Stochastic Oscillator 8.57 22.05

Price Performance

Historical Comparison
WAVE
IMRN

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

Share on Social Networks: